Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
JMS Co., Ltd. ( (JP:7702) ) has provided an announcement.
JMS Co., Ltd. reported a decrease in net sales and operating profit for the first quarter of the fiscal year ending March 2026. The company’s net sales fell by 3.9% compared to the previous year, while it recorded an operating loss of 176 million yen. The comprehensive income also showed a significant decline, and the capital adequacy ratio slightly decreased, indicating financial challenges. Despite these setbacks, the company maintained its dividend forecast, suggesting a commitment to returning value to shareholders.
More about JMS Co., Ltd.
JMS Co., Ltd. is a company listed on the Tokyo Standard stock exchange, operating in the general business category. The company is involved in the production and sale of medical devices and equipment, focusing on the healthcare industry.
Average Trading Volume: 29,125
Technical Sentiment Signal: Sell
Current Market Cap: Yen10.99B
For a thorough assessment of 7702 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money